Dialysis Market to Grow at a CAGR of 5.7% During the Forecast Period; Growing Shift to Home Dialysis Trends to Propel Market Expansion

The dialysis market size stood at USD 103.15 billion in 2025. The market is predicted to grow from USD 108.91 billion in 2026 to USD 170.19 billion by 2034, exhibiting a CAGR of 5.7% during the forecast period.

Fortune Business Insights™ presents this information in its report titled, “Dialysis Market Size, Share & Industry Analysis, By Type (Products {Equipment [Hemodialysis Machines (In-Center Hemodialysis Machines and Home Based Hemodialysis Machines) and Peritoneal Dialysis Equipment (Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD))] and Consumables [Dialyzers, Dialysate, Cyclers, Fluids, Access Products, and Others]} and Services), By Dialysis Type (Hemodialysis and Peritoneal Dialysis), By End User (Dialysis Centers & Hospitals and Home Care), and Regional Forecast, 2026-2034”. 

Increasing prevalence of chronic kidney diseases is leading to a surge in patients opting for renal therapy. This has led to an increase in demand for dialysis and related products including hemodialysis machines and dialysate. It has also allowed key companies to launch new products and expand their service offerings. Additionally, an increasing shift toward home dialysis is reshaping the market expansion globally. For instance, Northwest Kidney Centers inaugurated a new outpatient dialysis facility across the Panther Lake area of Kent. This has 11 dialysis stations and could provide accommodation for approximately 66 patients.

Collaboration Among Fresenius SE & Co. KGaA’s CRO Frenova, Nephronomics and GENEWIZ by Azenta Life Sciences to Fuel Market Development

In July 2025, Fresenius SE & Co. KGaA’s CRO Frenova declared a genomics collaboration with Nephronomics and GENEWIZ by Azenta Life Sciences. This collaboration advances precision kidney disease care and also expands the firm’s market position.

Surging Occurrence of Chronic Conditions and Accessibility to Hemodialysis Centers Augments Market Growth

Growing prevalence of chronic kidney diseases is one of the major drivers for global dialysis market growth. This has led to an increase in the number of patients demanding renal replacement therapy including hemodialysis and peritoneal dialysis. This has supported the demand for dialysis machines, bloodlines, dialyzers, catheters, concentrates, and related consumables. Additionally, this has also allowed different developed and developing countries access healthcare centres particularly for hemodialysis with efficient infrastructure. Investors are focusing on increasing the network for renal treatment centres across China, India and Mexico.

Conversely, the risk and complications related to dialysis procedures is hindering market growth.

Top Players Emphasize Introduction of Novel Products to Strengthen Their Market Presence

The global market is characterized by the presence of different key industry players. These firms are adopting strategies including getting regulatory approvals, expanding geographic presence and introducing novel products to sustain growing competition.

Notable Industry Development

• September 2025: Mozarc Medical collaborated with DK Medical Technology (Suzhou) Co., Ltd. (DK Medtech). This aims to reinforce PTA balloon technology in the U.S. AV access market.

List of the Companies Profiled in the Report

• B Braun SE (Germany)
• Fresenius Medical Care AG (Germany)
• Mozarc Medical Holding LLC. (U.S.)
• DaVita Inc. (U.S.)
• NIPRO (Japan)
• Asahi Kasei Medical Co., Ltd. (Japan)
• Diaverum (Sweden)
• Kimal (U.K.)
• BD (U.S.)
• Vantive (U.S.)
• WEIGAO GROUP (China)
• BAIN MEDICAL EQUIPMENT(GUANGZHOU)CO., LTD (China)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/dialysis-market-102367

Further Report Findings

• North America held the highest dialysis market share, owing to the higher prevalence of ESDR and CKD especially across Canada and the U.S. Additionally, increasing treatment rate also boosts the regional market growth.
• Market growth in Europe is driven by surging geriatric population rate suffering from renal diseases, and patients receiving dialysis therapy.
• Market expansion in Asia Pacific is propelled by funding from public organizations to enhance accessibility of renal care and increasing accessibility to dialysis services.
• In terms of type, the service segment led the market in 2025, owing to evolution of well-equipped renal care facilities for acute and chronic care globally.
• By dialysis type, the hemodialysis segment dominated due to clinical benefits related to hemodialysis including less time and adoption of Arteriovenous (AV) fistula.

Table of Segmentation